NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	27/02/2020
Target sample size	84
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : gilteritinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : idarubicin Therapeutic category code : 423 Antitumor antibiotics and preparations Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : cytarabine Therapeutic category code : 422 Antimetabolic agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	pharmacokinetics efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy safety

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria